CDCA5 peptides and vaccines including the same

Details for Australian Patent Application No. 2011236397 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nakamura, Yusuke; Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko; Watanabe, Tomohisa

Agent Davies Collison Cave

Pub. Number AU-A-2011236397

PCT Pub. Number WO2011/125334

Priority 61/322,676 09.04.10 US

Filing date 7 April 2011

Wipo publication date 13 October 2011

International Classifications

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 5/0781 Undifferentiated human, animal or plant cells, e.g. cell lines - B cells

C12N 5/0783 Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/125334 Priority application(s): WO2011/125334

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011236431-Display device with touch panel

2011236333-Display device and drive method therefor